mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.3 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.3 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.3 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |